Story thread · 2 reports / 1 sources
Novo CEO Says Drugmaker Needs to “Rethink” its Obesity Strategy
finance.yahoo.com · 1d
First report: Novo is Building a Strong Base to Address Unmet Needs in Diabetes and Obesity Drugs — finance.yahoo.com, 1d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.